Intervention Review

Depot pipotiazine palmitate and undecylenate for schizophrenia

  1. Mohandas Dinesh1,*,
  2. Anthony David2,
  3. Seema N Quraishi2

Editorial Group: Cochrane Schizophrenia Group

Published Online: 19 JUL 2004

Assessed as up-to-date: 5 MAY 2004

DOI: 10.1002/14651858.CD001720.pub2

How to Cite

Dinesh M, David A, Quraishi SN. Depot pipotiazine palmitate and undecylenate for schizophrenia. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD001720. DOI: 10.1002/14651858.CD001720.pub2.

Author Information

  1. 1

    Leeds Community Mental health Teaching NHS Trust, Psychiatry, Leeds, W Yorkshire, UK

  2. 2

    Institute of Psychiatry, London, UK

*Mohandas Dinesh, Psychiatry, Leeds Community Mental health Teaching NHS Trust, Department of Liaison Psychiatry, Becklin centre, Alma Street, Leeds, W Yorkshire, LS9 7BE, UK. dineshmohandas@hotmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 JUL 2004

SEARCH

  1. Current Version

    Depot pipotiazine palmitate and undecylenate for schizophrenia

    Mohandas Dinesh, Anthony David and Seema N Quraishi

    Article first published online: 19 JUL 2004 | DOI: 10.1002/14651858.CD001720.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Depot pipothiazine palmitate and undecylenate for schizophrenia

    A David and SN Quraishi

    Article first published online: 23 JUL 2001 | DOI: 10.1002/14651858.CD001720